Session Details

U009 Pediatric Dermatology for the Adult Dermatologist

Fri, Mar 19, 7:30 AM - 8:30 AM
1 CME Available Focus Session

DESCRIPTION

Spitz neoplasms represent a spectrum of melanocytic lesions ranging from benign Spitz nevi to atypical Spitz tumors and malignant Spitz melanoma. Evolving terminology, advances in molecular diagnostics, and changing management recommendations present unique challenges for practicing dermatologists. This session will outline an approach to evaluating and managing Spitz neoplasms in children. Emphasis will be placed on clinical recognition, interpretation of histopathologic and molecular findings, and evidence-based recommendations for biopsy, surgical management, surveillance, and referral.

LEARNING OBJECTIVES

1.

Differentiate pediatric Spitz and spitzoid neoplasms based on current classification and terminology.

2.

Interpret histopathologic and molecular findings to assess the malignant potential of Spitz neoplasms and guide clinical decision-making.

3.

Develop a treatment strategy for pediatric patients with Spitz neoplasms, with special emphasis on our knowledge of natural history and outcomes in children and adolescents.

SCHEDULE

7:30 AM

One Lesion, Many Questions: Introducing the Spitz Spectrum

Valerie Margaret Carlberg, MD, FAAD

7:35 AM

Spitz Neoplasms in 2027: Updates in Classification and Terminology

Stephen Raymond Humphrey, MD, FAAD

7:45 AM

Decoding the Spitz Neoplasm Pathology Report

Kara Elisabeth Young, MD, FAAD

8:00 AM

Managing Spitz Neoplasms: When to Observe, Excise, or Escalate

Elena B. Hawryluk, MD, PhD, FAAD

8:15 AM

Question and Answer

DIRECTOR

Valerie Margaret Carlberg, MD, FAAD

Valerie Margaret Carlberg, MD, FAAD

Medical College of Wisconsin

SPEAKERS

Elena B. Hawryluk, MD, PhD, FAAD

Elena B. Hawryluk, MD, PhD, FAAD

Stephen Raymond Humphrey, MD, FAAD

Stephen Raymond Humphrey, MD, FAAD

Kara Elisabeth Young, MD, FAAD

Kara Elisabeth Young, MD, FAAD

DISCLOSURES

Valerie Margaret Carlberg, MD, FAAD

No financial relationships exist with ineligible companies.

Elena B. Hawryluk, MD, PhD, FAAD

Apogee Therapeutics – Advisory Board(Honoraria); UpToDate, Inc – Other(Other Financial Benefit);

Stephen Raymond Humphrey, MD, FAAD

AbbVie – Investigator(Grants/Research Funding); Celgene – Investigator(Grants/Research Funding); Dermsquared – Speaker/Faculty Education(Honoraria); Eli Lilly – Investigator(Grants/Research Funding); Elsevier Inc. – Independent Contractor(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding);

Kara Elisabeth Young, MD, FAAD

No financial relationships exist with ineligible companies.